Report cover image

Nicergoline Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 137 Pages
SKU # APRC20352469

Description

Summary

According to APO Research, the global Nicergoline market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Nicergoline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nicergoline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Nicergoline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Nicergoline include Shandong Qidu Pharmaceutical Co. Ltd., Shandong Fangming Pharmaceutical Group Co. Ltd., Pfizer Pharmaceutical Co., Ltd., Hebei Lingding Biotechnology Co., Ltd., Hainan Zambon Pharmaceutical Co. Ltd, Hainan General Kangli Pharmaceutical Co. Ltd., Hainan Poly Pharm Co. Ltd, Fengchen and Tocris Bioscience, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nicergoline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicergoline.

The report will help the Nicergoline manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Nicergoline market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nicergoline market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Nicergoline Segment by Company

Shandong Qidu Pharmaceutical Co. Ltd.
Shandong Fangming Pharmaceutical Group Co. Ltd.
Pfizer Pharmaceutical Co., Ltd.
Hebei Lingding Biotechnology Co., Ltd.
Hainan Zambon Pharmaceutical Co. Ltd
Hainan General Kangli Pharmaceutical Co. Ltd.
Hainan Poly Pharm Co. Ltd
Fengchen
Tocris Bioscience
Teva API
Solarium Pharmaceuticals
Selleck Chemicals
Pharmacia
Olon Group
LGC
Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
FAREVA
DEAFARMA
Nicergoline Segment by Type

For Injection
For Oral
Nicergoline Segment by Application

Alzheimer's Disease (AD)
Arterial Hypertension
Cerebral Thrombosis
Others
Nicergoline Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicergoline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicergoline and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicergoline.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nicergoline manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nicergoline by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nicergoline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Table of Contents

137 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Nicergoline Market Size (2020-2031)
2.2.2 Global Nicergoline Sales (2020-2031)
2.2.3 Global Nicergoline Market Average Price (2020-2031)
2.3 Nicergoline by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 For Injection
2.3.3 For Oral
2.4 Nicergoline by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Alzheimer's Disease (AD)
2.4.3 Arterial Hypertension
2.4.4 Cerebral Thrombosis
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Nicergoline Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Nicergoline Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Nicergoline Revenue of Manufacturers (2020-2025)
3.4 Global Nicergoline Average Price by Manufacturers (2020-2025)
3.5 Global Nicergoline Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Nicergoline, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Nicergoline, Product Type & Application
3.8 Global Manufacturers of Nicergoline, Established Date
3.9 Global Nicergoline Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Shandong Qidu Pharmaceutical Co. Ltd.
4.1.1 Shandong Qidu Pharmaceutical Co. Ltd. Company Information
4.1.2 Shandong Qidu Pharmaceutical Co. Ltd. Business Overview
4.1.3 Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
4.1.5 Shandong Qidu Pharmaceutical Co. Ltd. Recent Developments
4.2 Shandong Fangming Pharmaceutical Group Co. Ltd.
4.2.1 Shandong Fangming Pharmaceutical Group Co. Ltd. Company Information
4.2.2 Shandong Fangming Pharmaceutical Group Co. Ltd. Business Overview
4.2.3 Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Product Portfolio
4.2.5 Shandong Fangming Pharmaceutical Group Co. Ltd. Recent Developments
4.3 Pfizer Pharmaceutical Co., Ltd.
4.3.1 Pfizer Pharmaceutical Co., Ltd. Company Information
4.3.2 Pfizer Pharmaceutical Co., Ltd. Business Overview
4.3.3 Pfizer Pharmaceutical Co., Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Pfizer Pharmaceutical Co., Ltd. Nicergoline Product Portfolio
4.3.5 Pfizer Pharmaceutical Co., Ltd. Recent Developments
4.4 Hebei Lingding Biotechnology Co., Ltd.
4.4.1 Hebei Lingding Biotechnology Co., Ltd. Company Information
4.4.2 Hebei Lingding Biotechnology Co., Ltd. Business Overview
4.4.3 Hebei Lingding Biotechnology Co., Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Hebei Lingding Biotechnology Co., Ltd. Nicergoline Product Portfolio
4.4.5 Hebei Lingding Biotechnology Co., Ltd. Recent Developments
4.5 Hainan Zambon Pharmaceutical Co. Ltd
4.5.1 Hainan Zambon Pharmaceutical Co. Ltd Company Information
4.5.2 Hainan Zambon Pharmaceutical Co. Ltd Business Overview
4.5.3 Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Product Portfolio
4.5.5 Hainan Zambon Pharmaceutical Co. Ltd Recent Developments
4.6 Hainan General Kangli Pharmaceutical Co. Ltd.
4.6.1 Hainan General Kangli Pharmaceutical Co. Ltd. Company Information
4.6.2 Hainan General Kangli Pharmaceutical Co. Ltd. Business Overview
4.6.3 Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
4.6.5 Hainan General Kangli Pharmaceutical Co. Ltd. Recent Developments
4.7 Hainan Poly Pharm Co. Ltd
4.7.1 Hainan Poly Pharm Co. Ltd Company Information
4.7.2 Hainan Poly Pharm Co. Ltd Business Overview
4.7.3 Hainan Poly Pharm Co. Ltd Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Hainan Poly Pharm Co. Ltd Nicergoline Product Portfolio
4.7.5 Hainan Poly Pharm Co. Ltd Recent Developments
4.8 Fengchen
4.8.1 Fengchen Company Information
4.8.2 Fengchen Business Overview
4.8.3 Fengchen Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Fengchen Nicergoline Product Portfolio
4.8.5 Fengchen Recent Developments
4.9 Tocris Bioscience
4.9.1 Tocris Bioscience Company Information
4.9.2 Tocris Bioscience Business Overview
4.9.3 Tocris Bioscience Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Tocris Bioscience Nicergoline Product Portfolio
4.9.5 Tocris Bioscience Recent Developments
4.10 Teva API
4.10.1 Teva API Company Information
4.10.2 Teva API Business Overview
4.10.3 Teva API Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Teva API Nicergoline Product Portfolio
4.10.5 Teva API Recent Developments
4.11 Solarium Pharmaceuticals
4.11.1 Solarium Pharmaceuticals Company Information
4.11.2 Solarium Pharmaceuticals Business Overview
4.11.3 Solarium Pharmaceuticals Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Solarium Pharmaceuticals Nicergoline Product Portfolio
4.11.5 Solarium Pharmaceuticals Recent Developments
4.12 Selleck Chemicals
4.12.1 Selleck Chemicals Company Information
4.12.2 Selleck Chemicals Business Overview
4.12.3 Selleck Chemicals Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Selleck Chemicals Nicergoline Product Portfolio
4.12.5 Selleck Chemicals Recent Developments
4.13 Pharmacia
4.13.1 Pharmacia Company Information
4.13.2 Pharmacia Business Overview
4.13.3 Pharmacia Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Pharmacia Nicergoline Product Portfolio
4.13.5 Pharmacia Recent Developments
4.14 Olon Group
4.14.1 Olon Group Company Information
4.14.2 Olon Group Business Overview
4.14.3 Olon Group Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Olon Group Nicergoline Product Portfolio
4.14.5 Olon Group Recent Developments
4.15 LGC
4.15.1 LGC Company Information
4.15.2 LGC Business Overview
4.15.3 LGC Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.15.4 LGC Nicergoline Product Portfolio
4.15.5 LGC Recent Developments
4.16 Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
4.16.1 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Company Information
4.16.2 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Business Overview
4.16.3 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
4.16.5 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Recent Developments
4.17 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
4.17.1 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Company Information
4.17.2 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Business Overview
4.17.3 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.17.4 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
4.17.5 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Recent Developments
4.18 FAREVA
4.18.1 FAREVA Company Information
4.18.2 FAREVA Business Overview
4.18.3 FAREVA Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.18.4 FAREVA Nicergoline Product Portfolio
4.18.5 FAREVA Recent Developments
4.19 DEAFARMA
4.19.1 DEAFARMA Company Information
4.19.2 DEAFARMA Business Overview
4.19.3 DEAFARMA Nicergoline Sales, Revenue and Gross Margin (2020-2025)
4.19.4 DEAFARMA Nicergoline Product Portfolio
4.19.5 DEAFARMA Recent Developments
5 Global Nicergoline Market Scenario by Region
5.1 Global Nicergoline Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Nicergoline Sales by Region: 2020-2031
5.2.1 Global Nicergoline Sales by Region: 2020-2025
5.2.2 Global Nicergoline Sales by Region: 2026-2031
5.3 Global Nicergoline Revenue by Region: 2020-2031
5.3.1 Global Nicergoline Revenue by Region: 2020-2025
5.3.2 Global Nicergoline Revenue by Region: 2026-2031
5.4 North America Nicergoline Market Facts & Figures by Country
5.4.1 North America Nicergoline Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Nicergoline Sales by Country (2020-2031)
5.4.3 North America Nicergoline Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.5 Europe Nicergoline Market Facts & Figures by Country
5.5.1 Europe Nicergoline Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Nicergoline Sales by Country (2020-2031)
5.5.3 Europe Nicergoline Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Nicergoline Market Facts & Figures by Country
5.6.1 Asia Pacific Nicergoline Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Nicergoline Sales by Country (2020-2031)
5.6.3 Asia Pacific Nicergoline Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Nicergoline Market Facts & Figures by Country
5.7.1 South America Nicergoline Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Nicergoline Sales by Country (2020-2031)
5.7.3 South America Nicergoline Revenue by Country (2020-2031)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Nicergoline Market Facts & Figures by Country
5.8.1 Middle East and Africa Nicergoline Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Nicergoline Sales by Country (2020-2031)
5.8.3 Middle East and Africa Nicergoline Revenue by Country (2020-2031)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Nicergoline Sales by Type (2020-2031)
6.1.1 Global Nicergoline Sales by Type (2020-2031) & (K Units)
6.1.2 Global Nicergoline Sales Market Share by Type (2020-2031)
6.2 Global Nicergoline Revenue by Type (2020-2031)
6.2.1 Global Nicergoline Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Nicergoline Revenue Market Share by Type (2020-2031)
6.3 Global Nicergoline Price by Type (2020-2031)
7 Segment by Application
7.1 Global Nicergoline Sales by Application (2020-2031)
7.1.1 Global Nicergoline Sales by Application (2020-2031) & (K Units)
7.1.2 Global Nicergoline Sales Market Share by Application (2020-2031)
7.2 Global Nicergoline Revenue by Application (2020-2031)
7.2.1 Global Nicergoline Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Nicergoline Revenue Market Share by Application (2020-2031)
7.3 Global Nicergoline Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Nicergoline Value Chain Analysis
8.1.1 Nicergoline Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Nicergoline Production Mode & Process
8.2 Nicergoline Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Nicergoline Distributors
8.2.3 Nicergoline Customers
9 Global Nicergoline Analyzing Market Dynamics
9.1 Nicergoline Industry Trends
9.2 Nicergoline Industry Drivers
9.3 Nicergoline Industry Opportunities and Challenges
9.4 Nicergoline Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.